Yi Chu

2.7k total citations · 1 hit paper
66 papers, 2.1k citations indexed

About

Yi Chu is a scholar working on Molecular Biology, Epidemiology and Physiology. According to data from OpenAlex, Yi Chu has authored 66 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 13 papers in Epidemiology and 11 papers in Physiology. Recurrent topics in Yi Chu's work include Salivary Gland Disorders and Functions (6 papers), Oral microbiology and periodontitis research (6 papers) and Cancer-related molecular mechanisms research (6 papers). Yi Chu is often cited by papers focused on Salivary Gland Disorders and Functions (6 papers), Oral microbiology and periodontitis research (6 papers) and Cancer-related molecular mechanisms research (6 papers). Yi Chu collaborates with scholars based in China, United States and New Zealand. Yi Chu's co-authors include Mingzuo Jiang, Jie Liang, Bing Xu, Yongzhan Nie, Nan Wu, Kaichun Wu, Bing Xu, Daiming Fan, Yuying Han and Xin Xie and has published in prestigious journals such as Applied Physics Letters, Nature Cell Biology and Journal of Agricultural and Food Chemistry.

In The Last Decade

Yi Chu

64 papers receiving 2.1k citations

Hit Papers

Gasdermin D plays a key role as a pyroptosis executor of ... 2017 2026 2020 2023 2017 100 200 300

Peers

Yi Chu
Kyungsun Choi South Korea
Na Liu China
Péter Hamar Hungary
Qing Xu China
Yi Chu
Citations per year, relative to Yi Chu Yi Chu (= 1×) peers Meidong Liu

Countries citing papers authored by Yi Chu

Since Specialization
Citations

This map shows the geographic impact of Yi Chu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi Chu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi Chu more than expected).

Fields of papers citing papers by Yi Chu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yi Chu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi Chu. The network helps show where Yi Chu may publish in the future.

Co-authorship network of co-authors of Yi Chu

This figure shows the co-authorship network connecting the top 25 collaborators of Yi Chu. A scholar is included among the top collaborators of Yi Chu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yi Chu. Yi Chu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chu, Yi, Yuting Liu, Liangfu Zhou, et al.. (2025). Multiomics Reveal the Effects and Regulatory Mechanism of Naringin on Metabolic Dysfunction‐Associated Fatty Liver Disease of Laying Hens. Molecular Nutrition & Food Research. 69(12). e70082–e70082. 1 indexed citations
2.
Chu, Yi, Zhe Li, Yang Su, et al.. (2025). Multi-Omics Reveal the Effects and Regulatory Mechanism of Dietary Magnolol Supplementation on Production Performance of Post-Peak Laying Hens. Journal of Agricultural and Food Chemistry. 73(7). 4027–4041. 2 indexed citations
3.
Chu, Yi, et al.. (2024). The natural compounds, Magnolol or Honokiol, promote adipose tissue browning and resist obesity through modulating PPARα/γ activity. European Journal of Pharmacology. 969. 176438–176438. 10 indexed citations
4.
Wang, Jie, Ting Wei, Yi Chu, et al.. (2024). Inhibition of miR-194-5p avoids DUSP9 downregulation thus limiting sepsis-induced cardiomyopathy. Scientific Reports. 14(1). 20313–20313. 4 indexed citations
6.
Gao, Xiaoliang, Yi Chu, Weijie Wang, et al.. (2023). Detrimental role of SIX1 in hepatic lipogenesis and fibrosis of non‐alcoholic fatty liver disease. Liver International. 43(7). 1473–1485. 4 indexed citations
7.
Mao, Liufeng, Lijie Peng, Xiaomei Ren, et al.. (2022). Discovery of JND003 as a New Selective Estrogen-Related Receptor α Agonist Alleviating Nonalcoholic Fatty Liver Disease and Insulin Resistance. PubMed. 2(3). 282–296. 7 indexed citations
8.
Han, Yuying, Xiaoliang Gao, Nan Wu, et al.. (2022). Long noncoding RNA LINC00239 inhibits ferroptosis in colorectal cancer by binding to Keap1 to stabilize Nrf2. Cell Death and Disease. 13(8). 742–742. 54 indexed citations
9.
Xu, Xin‐Jian, Yi Chu, Pengfei Yang, et al.. (2021). Chondrocyte Adipogenic Differentiation in Softening Osteoarthritic Cartilage. Journal of Dental Research. 101(6). 655–663. 7 indexed citations
10.
Zhang, Jing, Haitao Yang, M. Zhang, et al.. (2021). Mineral deposition intervention through reduction of phosphorus intake suppresses osteoarthritic lesions in temporomandibular joint. Osteoarthritis and Cartilage. 29(9). 1370–1381. 4 indexed citations
11.
Li, Weiwei, Yiming Ma, Hongwei Li, et al.. (2021). Protease-activated receptor 2 stabilizes Bcl-xL and regulates EGFR–targeted therapy response in colorectal cancer. Cancer Letters. 517. 14–23. 16 indexed citations
12.
Chu, Yi, Mingzuo Jiang, Nan Wu, et al.. (2020). O-GlcNAcylation of SIX1 enhances its stability and promotes Hepatocellular Carcinoma Proliferation. Theranostics. 10(21). 9830–9842. 49 indexed citations
13.
Wu, Nan, Mingzuo Jiang, Haiming Liu, et al.. (2020). LINC00941 promotes CRC metastasis through preventing SMAD4 protein degradation and activating the TGF-β/SMAD2/3 signaling pathway. Cell Death and Differentiation. 28(1). 219–232. 125 indexed citations
14.
Han, Yuying, Nan Wu, Mingzuo Jiang, et al.. (2019). Long non‐coding RNA MYOSLID functions as a competing endogenous RNA to regulate MCL‐1 expression by sponging miR‐29c‐3p in gastric cancer. Cell Proliferation. 52(6). e12678–e12678. 53 indexed citations
15.
Jiang, Mingzuo, Nan Wu, Xi Chen, et al.. (2019). Pathogenesis of and major animal models used for nonalcoholic fatty liver disease. Journal of International Medical Research. 47(4). 1453–1466. 24 indexed citations
16.
Wu, Nan, Yuying Han, Haiming Liu, et al.. (2018). miR-5590-3p inhibited tumor growth in gastric cancer by targeting DDX5/AKT/m-TOR pathway. Biochemical and Biophysical Research Communications. 503(3). 1491–1497. 34 indexed citations
17.
Chen, Di, Li Xu, Xiaowei Li, et al.. (2018). Enah overexpression is correlated with poor survival and aggressive phenotype in gastric cancer. Cell Death and Disease. 9(10). 998–998. 17 indexed citations
18.
20.
Li, Honghua, Hui‐Yun Wang, Danielle M. Greenawalt, et al.. (2009). Identification of possible genetic alterations in the breast cancer cell line MCF-7 using high-density SNP genotyping microarray. Journal of Carcinogenesis. 8(1). 6–6. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026